“Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3)” (2009) Hematology Meeting Reports (formerly Haematologica Reports), 2(3). doi:10.4081/hmr.v2i3.365.